Global Bio-Banking market Research and Forecast 2018-2023

  • ID: 4537390
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Dec 31st 2018
1 of 4

FEATURED COMPANIES

  • Affymetrix, Inc
  • Bayer Schering Pharma Ag
  • Bristol-Myers Squibb Co
  • Exiqon Life Sciences
  • Johnson & Johnson Ltd
  • Pfizer Inc
  • MORE
Global Biobanking market is expected to grow at a CAGR of 7.2% during 2018-2023. A biobank is a biorepository that is used to store biological samples of human to be used in research. Most of the bio-banked samples are used by research groups for the development of new tests and effective treatment of cancer. The growth of the market has been propelled by cohesive government policies and funding from government and private ventures in biobanks. Large biobanks were supported by government and charitable organizations while private funding maintains the pharmaceutical biobanks. For an instance, in the US, Cancer Human Biobank, Bethesda, MD (the caHUB) was developed and supported by the National Cancer Institute (NCI) for the preservation of high-quality human cancer tissue samples for medical research.
Moreover, the other factors contributing to the growth of the market include development in genomic research and other research programs such as clinical proteomics tumor analysis consortium.

Additionally, increasing demand for cost-effective drug discovery, and advancement in biobanking are contributing significantly into the growth of the market. However, issues regarding biospecimen sample procurement and strict regulatory framework may affect the growth of the global biobanking market.

Geographically, the global biobanking market has been divided into North America, Europe, Asia Pacific and Rest of the World. North America has been predicted to dominate the global bio banking market owing to increasing research in cell and gene therapy, and regenerative medicine. The companies contributing to the growth of global biobanking market are Abbott Laboratories, Bayer Schering Pharma AG, Cancer genetics, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson Ltd., Merck & Company, Inc., Novartis AG, and Pfizer Inc. Majority of the biobanking market players have focus on various strategies such as acquisition or entering into strategic alliance with other major players to stay competitive and enhance their presence. Recently in March, 2017, UK biobank has taken an initiative with GSK and the Regeneron Genetics Center (RGC). Such strategies provides valuable insights to the researchers supporting the advancements in the development of new medicines for life threatening diseases.

Market Segmentation:
1. Global biobanking market by sample type
2. Global biobanking market by application

The Report covers:
  • Comprehensive Research Methodology of Global Biobanking Market.
  • This report also includes detailed and extensive market overview with Analyst insights & key market trends.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Biobanking Market.
  • Insights about market determinants which are stimulating the Global Biobanking Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Affymetrix, Inc
  • Bayer Schering Pharma Ag
  • Bristol-Myers Squibb Co
  • Exiqon Life Sciences
  • Johnson & Johnson Ltd
  • Pfizer Inc
  • MORE
Chapter 1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

Chapter 2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
2.4. Pipeline Analysis

Chapter 3. Market Determinant
3.1. Motivators
3.1.1. Cohesive Government Policies
3.1.2. High Incidence and Prevalence of Chronic Diseases
3.1.3. Development in Genomics Research
3.1.4. Rising Demand For Cost Efficient Drug Discovery
3.1.5. Advancement in Biobanking
3.2. Restraints
3.2.1. Regulatory Framework
3.2.2. High Cost of Automation in Biobanking
3.2.3. Issues Regarding Biospecimen Sample Procurement
3.3. Opportunities
3.3.1. Rising Hereditary Disorder
3.3.2. Increasing R&D of Cell Therapies
3.3.3. Growing Government Funding in Biomedical and Biotechnology Industries
3.3.4. Increasing Public/Private Partnership

Chapter 4. Market Segmentation
4.1. Global Biobanking Market By Sample Type
4.1.1. Blood Products
4.1.2. Human Tissues
4.1.3. Nucleic Acid
4.1.4. Biological Fluid
4.1.5. Human Waste Product
4.2. Global Biobanking Market By Application
4.2.1. Clinical Research
4.2.2. Regenerative Medicine

Chapter 5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

Chapter 6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the World

Chapter 7. Company Profiles
7.1. Abbott Laboratories Inc
7.2. Affymetrix, Inc
7.3. Asterand Plc
7.4. Astrazeneca Ltd
7.5. Bayer Schering Pharma Ag
7.6. Biochain-Genomics
7.7. Biostorage Technologies, Inc.
7.8. Boehringer Ingelheim Gmbh
7.9. Bristol-Myers Squibb Co
7.10. Cancer Genetics
7.11. Daiichi Sankyo Company, Ltd
7.12. Eli Lilly and Company
7.13. Exiqon Life Sciences
7.14. F. Hoffman-La Roche Ag
7.15. Glaxosmithkline
7.16. Johnson & Johnson Ltd
7.17. Merck & Co.
7.18. Millennium Pharmaceuticals
7.19. Novartis Ag
7.20. Pfizer Inc
7.21. Sanofi-Aventis
7.22. Scipac
7.23. Takeda Pharmaceuticals Ltd
7.24. Teva Pharmaceutical Industries Ltd.

List of Tables:
Table 1 Global Biobanking Market Research and Analysis, By Geography, 2017-2023 ($ Millions)
Table 2 Global Biobanking Market Research and Analysis, By Sample Type, 2017-2023 ($ Millions)
Table 3 Global Blood Products Market Research and Analysis 2017-2023 ($ Millions)
Table 4 Global Human Tissues Market Research and Analysis, 2017-2023, ($ Millions)
Table 5 Global Nucleic Acid Market Research and Analysis, 2017-2023, ($ Millions)
Table 6 Global Biological Fluid Market Research and Analysis, 2017-2023, ($ Millions)
Table 7 Global Human Waste Product Market Research and Analysis, 2017-2023, ($ Millions)
Table 8 Global Biobanking Market Research and Analysis, By Application, 2017-2023, ($ Millions)
Table 9 Global Clinical Research Market Research and Analysis, 2017-2023, ($ Millions)
Table 10 Global Regenerative Medicine Market Research and Analysis, 2017-2023, ($ Millions)
Table 11 North American Biobanking Market Research and Analysis, By Sample Type, 2017-2023, ($ Millions)
Table 12 North American Biobanking Market Research and Analysis, By Application, 2017-2023, ($ Millions)
Table 13 European Biobanking Market Research and Analysis, By Sample Type, 2017-2023, ($ Millions)
Table 14 European Biobanking Market Research and Analysis, By Application, 2017-2023, ($ Millions)
Table 15 APAC Market Research and Analysis, By Sample Type, 2017-2023, ($ Millions)
Table 16 APAC Biobanking Market Research and Analysis, By Application, 2017-2023, ($ Millions)

List of Figures:
Figure 1 Global Biobanking Market Share, By Sample Type, 2017 Vs 2023, (%)
Figure 2 Global Biobanking Market Share, By Application, 2017 Vs 2023, (%)
Figure 3 North American Biobanking Market Size, 2017-2023, ($ Millions)
Figure 4 Us Biobanking Market Size, 2017-2023, ($ Millions)
Figure 5 Canada Biobanking Market Size, 2017-2023, ($ Millions)
Figure 6 European Biobanking Market Size, 2017-2023, ($ Millions)
Figure 7 UK Biobanking Market Size, 2017-2023, ($ Millions)
Figure 8 France Biobanking Market Size, 2017-2023, ($ Millions)
Figure 9 Germany Biobanking Market Size, 2017-2023, ($ Millions)
Figure 10 Italy Biobanking Market Size, 2017-2023, ($ Millions)
Figure 11 Spain Biobanking Market Size, 2017 and 2023, ($ Millions)
Figure 12 ROE Biobanking Market Size, 2017-2023, ($ Millions)
Figure 13 Asia Pacific Biobanking Market Size, 2017-2023, ($ Millions)
Figure 14 India Biobanking Market Size, 2017-2023, ($ Millions)
Figure 15 China Biobanking Market Size, 2017-2023, ($ Millions)
Figure 16 Japan Biobanking Market Size, 2017-2023, ($ Millions)
Figure 17 ROAPAC Biobanking Market Size, 2017-2023, ($ Millions)
Figure 18 Rest of the World Biobanking Market Size, 2017-2023, ($ Millions)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Affymetrix, Inc
  • Asterand Plc
  • Astrazeneca Ltd
  • Bayer Schering Pharma Ag
  • Biochain-Genomics
  • Biostorage Technologies, Inc.
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb Co
  • Cancer Genetics
  • Daiichi Sankyo Company, Ltd
  • Eli Lilly And Company
  • Exiqon Life Sciences
  • F. Hoffman-La Roche Ag
  • Glaxosmithkline
  • Johnson & Johnson Ltd
  • Merck & Co.
  • Millennium Pharmaceuticals
  • Novartis Ag
  • Pfizer Inc
  • Sanofi-Aventis
  • Scipac
  • Takeda Pharmaceuticals Ltd
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll